enGene Therapeutics (ENGN) Profit After Tax (2023 - 2026)
enGene Therapeutics (ENGN) recorded Profit After Tax of -$32.5 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$28.99 million a year earlier.
Powered by 
Analysis
enGene Therapeutics (ENGN) Profit After Tax (2023 - 2026) Analysis & Trends
On a TTM basis, enGene Therapeutics' Profit After Tax came in at -$130.36 million as of Jul 31, 2026; for FY2025 (ended Oct 31, 2025), it came in at -$117.3 million.
- Across earlier fiscal years, Profit After Tax came in at -$55.14 million in FY2024, -$99.92 million in FY2023 and -$24.46 million in FY2022.
- Quarterly Profit After Tax has ranged from -$82.5 million in fiscal Q4 2023 to -$4.72 million in fiscal Q3 2023 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$30.23 million (Q2 2026), -$29.75 million (Q1 2026) and -$37.88 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 5.28 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.09 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -246.00 Mn |
| 10 | enGene Therapeutics | 132.69 Mn | 132.69 Mn | - | -32.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -32.50 Mn |
| Apr 30, 2026 | -30.23 Mn |
| Jan 31, 2026 | -29.75 Mn |
| Oct 31, 2025 | -37.88 Mn |
| Jul 31, 2025 | -28.99 Mn |
| Apr 30, 2025 | -25.82 Mn |
| Jan 31, 2025 | -24.62 Mn |
| Oct 31, 2024 | -15.30 Mn |
| Jul 31, 2024 | -14.15 Mn |
| Apr 30, 2024 | -14.98 Mn |
| Jan 31, 2024 | -10.71 Mn |
| Oct 31, 2023 | -82.50 Mn |
| Jul 31, 2023 | -4.72 Mn |
| Apr 30, 2023 | -5.28 Mn |
| Jan 31, 2023 | -7.42 Mn |
API Access
enGene Therapeutics Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();